Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

paxvax berna gmbh - haemagglutininum influenzae di tipo a (h1n1), neuraminidasum inactivatum (virus-stamm a/michigan/45/2015 (h1n1)-like: reassortant virus ivr-180 derivato da a/singapore/gp1908/2015), haemagglutininum influenzae a (h3n2), haemagglutininum influenzae b - injektionssuspension - haemagglutininum influenzae a (h1n1) mind.15 µg et neuraminidasum inactivatum (virus-stamm a/michigan/45/2015 (h1n1)-like: reassortant virus ivr-180 derived from a/singapore/gp1908/2015), haemagglutininum influenzae a (h3n2) mind.15 µg et neuraminidasum inactivatum (virus-stamm a/singapore/infimh-16-0019/2016 (h3n2)-like: reassortant virus ivr-186), haemagglutininum influenzae b mind.15 µg et neuraminidasum inactivatum (virus-stamm b/colorado/06/2017)-like: reassortant virus b/victoria/2/87_b/maryland/15/2016), adjuvans mf59: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. - aktive immunisierung gegen influenza für ältere menschen (65 anni oder älter), besonders für personen mit erhöhtem c'è un rischio per l'influenza-assoziierte komplikationen - impfstoffe

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

emergent biosolutions berna gmbh - haemagglutininum influenzae di tipo a (h1n1), neuraminidasum inactivatum (virus-stamm a/california/7/2009 x-179a) - siringhe preriempite - haemagglutininum influenzae di tipo a (h1n1) e neuraminidasum inactivatum (virus-stamm a/california/7/2009 x-179a) a 3,75 µg, adjuvans mf59: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acido citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesio chloridum hexahydricum, calcio chloridum dihydricum, acqua q.s. la sospensione per 0,25 ml. - vaccino influenzale pandemico - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

emergent biosolutions berna gmbh - haemagglutininum influenzae di tipo a (h1n1), neuraminidasum inactivatum (virus-stamm a/california/7/2009 x-181) - siringa preriempita - haemagglutininum influenzae di tipo a (h1n1) e neuraminidasum inactivatum (virus-stamm a/california/7/2009 x-181) 7.5 µg, adjuvans mf59: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acido citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesio chloridum hexahydricum, calcio chloridum dihydricum, acqua q.s. la sospensione 0,5 ml. - vaccino influenzale pandemico - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

emergent biosolutions berna gmbh - haemagglutininum influenzae di tipo a (h1n1), neuraminidasum inactivatum (virus-stamm a/california/7/2009 x-181) - mehrfachdosenbehältnis - haemagglutininum influenzae di tipo a (h1n1) e neuraminidasum inactivatum (virus-stamm a/california/7/2009 x-181) 7.5 µg, adjuvans mf59: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acido citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesio chloridum hexahydricum, calcio chloridum dihydricum, conserv.: thiomersalum 50 µg, acqua q.s. la sospensione 0,5 ml. - vaccino influenzale pandemico - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

medius ag - haemagglutininum influenzae a (h5n1), neuraminidasum inactivatum (virus-stamm a/vietnam/1194/2004 nibrg-14) - sospensione iniettabile in una siringa preriempita - haemagglutininum influenzae a (h5n1) et neuraminidasum inactivatum (virus-stamm a/vietnam/1194/2004 nibrg-14) 7.5 µg, adjuvans mf59c.1: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. - pandemico influenzale vaccino - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

medius ag - haemagglutininum influenzae a (h5n1), neuraminidasum inactivatum (virus-stamm a/vietnam/1194/2004 nibrg-14) - sospensione iniettabile in un flaconcino - haemagglutininum influenzae a (h5n1) et neuraminidasum inactivatum (virus-stamm a/vietnam/1194/2004 nibrg-14) 7.5 µg, adjuvans mf59c.1: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acidum citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, calcii chloridum dihydricum, conserv.: thiomersalum 50 µg, aqua ad iniectabile, q.s. ad suspensionem pro 0.5 ml. - pandemico influenzale vaccino - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - toxoidum diphtheriae, toxoidum tetani, toxoidum pertosse, haemagglutininum filamentosum (b. pertussis, pertactinum (b. pertussis, il virus della poliomielite di tipo 1 inactivatus (stamm mahoney), virus e poliomielite di tipo 2 inactivatus (stamm mef-1), un virus e la poliomielite di tipo 3 inactivatus (stamm saukett), polysaccharida haemophili influenzae di tipo b 20752 conjugata con toxoido tetani - pulver und suspension zur herstellung einer injektionssuspension - i) dtpa-ipv: toxoidum diphtheriae min. 30 u.i., toxoidum tetani min. 40 u.i., toxoidum pertussis 25 µg, haemagglutininum filamentosum (b. pertussis) 25 µg, pertactinum (b. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (stamm mahoney) 40 u., virus poliomyelitis typus 2 inactivatus (stamm mef-1) 8 u., virus poliomyelitis typus 3 inactivatus (stamm saukett) 32 u., aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini b sulfas, polysorbatum 80, formaldehydum. ii) hib: polysaccharida haemophili influenzae typus b 20752 conjugata cum toxoido tetani 10 µg, lactosum, pro praeparatione. i) et ii) corresp. dtpa-ipv + hib: toxoidum diphtheriae min. 30 u.i., toxoidum tetani min. 40 u.i., toxoidum pertussis 25 µg, haemagglutininum filamentosum (b. pertussis) 25 µg, pertactinum (b. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (stamm mahoney) 40 u., virus poliomyelitis typus 2 inactivatus (stamm mef-1) 8 u., virus poliomyelitis typus 3 inactivatus (stamm saukett) 32 u., polysaccharida haemophili influenzae typus b 20752 conjugata cum toxoido tetani 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 1.8 mg, medium 199, lactosum, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini b sulfas, polysorbatum 80, formaldehydum. - aktive immunisierung gegen diphtherie, tetanus, pertussis, poliomyelitis und haemophilus influenzae typ b, ab dem vollendeten 2. lebensmonat, auffrischimpfung (4. dosis), ab dem vollendeten 12. lebensmonat - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - toxoidum diphtheriae, toxoidum tetani, toxoidum pertosse, haemagglutininum filamentosum, pertactinum - sospensione iniettabile - toxoidum diphtheriae ≥ 2 u.i., toxoidum tetani ≥ 20 u.i., toxoidum pertussis 8 µg, haemagglutininum filamentosum 8 µg, pertactinum 2.5 µg, aluminium ut aluminii phosphas et aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 1.8 mg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, polysorbatum 80, formaldehydum. - attiva vaccinazione di richiamo contro la difterite, il tetano e la pertosse, che abbiano compiuto il 4. anni - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - toxoidum diphtheriae, toxoidum tetani, toxoidum pertussis, haemagglutininum filamentosum (b. pertussis), pertactinum (b. pertussis), virus poliomyelitis typus 1 inactivatus (stamm mahoney), virus poliomyelitis typus 2 inactivatus (stamm mef-1), virus poliomyelitis typus 3 inactivatus (stamm saukett) - sospensione iniettabile - toxoidum diphtheriae min. 30 u.i., toxoidum tetani min. 40 u.i., toxoidum pertussis 25 µg, haemagglutininum filamentosum (b. pertussis) 25 µg, pertactinum (b. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (stamm mahoney) 40 u.i., virus poliomyelitis typus 2 inactivatus (stamm mef-1) 8 u.i., virus poliomyelitis typus 3 inactivatus (stamm saukett) 32 u.i., aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini b sulfas, formaldehydum, polysorbatum 80. - vaccinazione primaria e di richiamo, contro difterite, tetano, pertosse e poliomielite, che abbiano compiuto il 2. mese di vita - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - toxoidum diphtheriae, toxoidum tetani, toxoidum pertussis, haemagglutininum filamentosum (b. pertussis), pertactinum (b. pertussis), virus poliomyelitis typus 1 inactivatus (stamm mahoney), virus poliomyelitis typus 2 inactivatus (stamm mef-1), virus poliomyelitis typus 3 inactivatus (stamm saukett), hepatitidis b viri antigenum adnr, polysaccharida haemophili influenzae typus b 20752 conjugata cum toxoido tetani - pulver und suspension zur herstellung einer injektionssuspension - i) dtpa-hepb-ipv: toxoidum diphtheriae min. 30 u.i., toxoidum tetani min. 40 u.i., toxoidum pertussis 25 µg, haemagglutininum filamentosum (b. pertussis) 25 µg, pertactinum (b. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (stamm mahoney) 40 u.i., virus poliomyelitis typus 2 inactivatus (stamm mef-1) 8 u.i., virus poliomyelitis typus 3 inactivatus (stamm saukett) 32 u.i., hepatitidis b viri antigenum adnr 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.2 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini b sulfas, formaldehydum, polysorbatum 20, polysorbatum 80. ii) hib: polysaccharida haemophili influenzae typus b 20752 conjugata cum toxoido tetani 10 µg, lactosum, aluminium 0.12 mg ut aluminii phosphas, pro praeparatione. i) et ii) corresp. dtpa-hepb-ipv + hib: toxoidum diphtheriae min. 30 u.i., toxoidum tetani min. 40 u.i., toxoidum pertussis 25 µg, haemagglutininum filamentosum (b. pertussis) 25 µg, pertactinum (b. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (stamm mahoney) 40 u.i., virus poliomyelitis typus 2 inactivatus (stamm mef-1) 8 u.i., virus poliomyelitis typus 3 inactivatus (stamm saukett) 32 u.i., hepatitidis b viri antigenum adnr 10 µg, polysaccharida haemophili influenzae typus b 20752 conjugata cum toxoido tetani 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.32 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, lactosum, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini b sulfas, formaldehydum, polysorbatum 20, polysorbatum 80. - vaccinazione primaria e di richiamo, contro difterite, tetano, pertosse, epatite b, poliomielite e haemophilus influenzae di tipo b, a partire dal compimento del 6. settimana di vita - vaccini